A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
At P&G we recently announced our ambition to achieve net zero greenhouse gas emissions across our supply chain and operations by 2040, from raw material to retailer.
P&G is seeking startups for sustainability and improved chemistry opportunities for Zero Waste Haircare and Device Amplified Chemistry.
P&G is looking for Novel Antimicrobial Solutions.
P&G is looking to understand the broad external ecosystem in the Future of Home space to assess potential new business opportunities and partnerships to accelerate innovation that is sustainable, smart, and delightful to consumers. We are looking for existing labs that are experimenting around the future of home or technology providers that have access to or could help us create a lab environment.
Leading pharmaceutical company in CNS seeks startups to improve performance of clinical trials.
Rich Bavasso CEO and Co-Founder, nQ Medical Nader Yaghoubi President and CEO, PathMaker Neurosystems Bobby Brooke Herrera Co-founder & Interim CEO, E25Bio Thanos Kosmidis Co-Founder & CEO, CareAcross Drew Arenth macro-eyes Zen Chu Senior Lecturer, MIT Sloan Jon Bloom Co-Founder and CEO, Podimetricsl Nigel Surridge Research Fellow, Roche Diabetes Care Inc. Antonio Melo Vice President, Digital Experience Center, , Humana Digital Health Analytics Anne Kim Cofounder & CEO, Secure AI Labs (SAIL) Brandon Busuito Founder & CEO, CoVerified Sam Shames Embr Labs